2019 CBD Research
400 mg CBD dose reduces cravings and anxiety in opiate addicts?
New research says: Yes
- In a double-blind placebo-controlled study at NYU, cannabidiol “significantly reduced both craving and anxiety” caused when heroin addicts were exposed to drug cues.
- CBD reduced heart rate response prompted by drug cues
- CBD reduced salivary cortisol levels prompted by drug cues.
- CBD caused “no significant effects on cognition”
- CBD caused “no serious adverse effects”
New CBD Study Published November 1, 2019
Our summary: This double-blind randomized placebo-controlled study assessed heroin addicts who were given CBD to help them reduce cravings and anxiety while attempting to quit heroin.
- Addicts were given either a 400mg CBD dose or an 800mg CBD dose daily for 3 days.
- Addicts were assessed 1 hour, 2 hours and 24 hours after taking the CBD product.
- They were also assessed again 7 days after finishing the 3-day course of 400mg or 800mg dose of CBD.
Evaluation: Addicts were assessed for:
- drug craving
- positive and negative affect
- physiological status
- In the CBD group (and not in the placebo group) addicts cravings for heroin and anxiety were significantly reduced.
- there is a “strong basis for further investigation of [cannabidiol] as a treatment option for opioid use disorder.”
More information on CBD for opioid abuse.
Check out this quick video on the signs and symptoms of opioid abuse.
Keywords: CBD; Heroin Addiction; Substance Abuse; Cannabis; Opioid Use Disorder